First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News

ETF Overview

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

Key Stats

• Today's Range: $25.57 to $25.57
• 50-Day Range: $24.01 to $26.39
• 52-Week Range: $23.28 to $29.72
• Volume: 173 shs
• Average Volume: 7,303 shs
• Market Capitalization: $13.94 million
• Assets Under Management: $20.46 million
• Dividend Yield: 1.89%
• Net Expense Ratio: 0.60%
• Aggregate Rating: Moderate Buy

FTXH ETF - Frequently Asked Questions

How have FTXH shares performed this year?

First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $26.97 on January 1st, 2025. Since then, FTXH shares have decreased by 4.9% and is now trading at $25.6390.
View the best growth stocks for 2025 here.

Who are First Trust Nasdaq Pharmaceuticals ETF's major shareholders?

Top institutional shareholders of First Trust Nasdaq Pharmaceuticals ETF include LPL Financial LLC (19.07%), Goldman Sachs Group Inc. (3.54%), Envestnet Asset Management Inc. (3.42%) and Cambridge Investment Research Advisors Inc. (3.01%).

How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF?

Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of First Trust Nasdaq Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust Nasdaq Pharmaceuticals ETF investors own include Digirad (DRAD), RAIT Financial Trust (RAS), Cummins (CMI), Cannabis Wheaton Income (CBWTF), Blueknight Energy Partners (BKEP), Biocept (BIOC) and Biocorrx (BICX).

Fund Details

• Issuer: First Trust
• Fund Name: First Trust Nasdaq Pharmaceuticals ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NASDAQ
• Current Symbol: NASDAQ:FTXH
• Inception Date: 9/20/2016
• Fund Manager: Daniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo
• Web: N/A
• Phone: 14089961010

Fund Focus

• Asset Class: Equity
• Benchmark: Nasdaq US Smart Pharmaceuticals Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 51

Fund Statistics

• Assets Under Management: $20.46 million
• Average Daily Volume: $2.34 thousand
• Discount/Premium: 0.03%

Administrator, Advisor and Custodian

• Administrator: The Bank of New York Mellon Corporation
• Advisor: First Trust Advisors L.P.
• Custodian: The Bank of New York Mellon Corporation
• Distributor: First Trust Portfolios L.P.
• Transfer Agent: The Bank of New York Mellon Corporation
• Trustee: N/A
• Lead Market Maker: Old Mission

Options

• Optionable: N/A
• Short Interest: 10,800 shs

Miscellaneous

• Outstanding Shares: 550,000
• Beta: 0.70
• Creation Unit: 50,000
• Creation Fee: $500.00